Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
Active, not recruiting · NCT03856658 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases | Carcinoma, Ductal, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic adenocarcinoma, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Active, not recruiting | Phase 2 | 2026-07-16 | NCT03856658 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Corewell Health West | 13 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Corewell Health West | Grand Rapids | United States | 8 |